Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3511-3520 Newer>

HBS Working Knowledge March 2, 2007 Jim Heskett	What Is the Government's Role in U.S. Healthcare? Are we addressing healthcare cost issues with the creativity they deserve?
Chemistry World March 2007 Derek Lowe	Opinion: In the Pipeline Do the benefits of pharmaceutical company mergers really outweigh the costs?
Managed Care February 2007 Maureen Glabman	Health Plans Can Learn From VHA Turnaround While plans, hospitals, and physician groups talk the talk, the Veterans Health Administration is walking the walk.
Managed Care February 2007 MargaretAnn Cross	How Much Trouble Does Health Care Marketing Cause? Whether for drugs, imaging, surgery, or emergency services, direct-to-consumer advertising sparks lively debate.
Managed Care February 2007 Maggie Mahar	Why Market Competition Will Not Mend Our Health Care System Doctors have a saying: 'Half of what we know is wrong.' In which half is the conventional wisdom that competition is society's best hope for improving quality and controlling costs?
Managed Care February 2007 John Marcille	It Probably Was No Picnic Working for Ken Kizer at the VHA The VHA turnaround happened to a great extent because of Kenneth Kizer.
Managed Care February 2007	Undertreatment of Childhood Obesity Blamed on Coding Undertreating childhood obesity may be tied to payment codes.
Managed Care February 2007	Headlines On Deadline ... Deaths from cancer fell for the second straight year... Giving physicians free electronic prescribing software has been suggested to prevent medication errors... simple patient education intervention encouraged patients to use medications more consistently and continuously...
The Motley Fool February 28, 2007 Brian Lawler	Mylan Denied ... for Now The generic-drug maker loses its court battle to overturn the patents on Pfizer's No. 2 drug. This is a minor negative for Mylan, but for Pfizer, those extra six months of marketing exclusivity mean billions of dollars.
The Motley Fool February 28, 2007 Brian Lawler	Bristol-Myers Stays Out of Trouble A federal monitor finds Bristol-Myers does not have to pay up over a questionable business deal.
<Older 3511-3520 Newer> Return to current articles.